Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to divest its international enterprises in the months to come. The ...

On Jan. 28, major orthopedic and spine device manufacturer Stryker announced plans to sell off its U.S. spinal implants business. Here are eight things for ASCs to know about the sale: 1. Stryker's ...

Stryker beats Q4 estimates with $6.44B revenue and $4.01 EPS, announces CFO retirement and spine implant business sale. Analysts raise Stryker price targets, citing strong sales, margin expansion ...

Wall Street analysts rerated Stryker Corp (NYSE:SYK) Wednesday after the company’s fourth-quarter print. Stryker reported quarterly earnings of $4.01 per share, which beat the analyst consensus ...